Using stress markers to improve health outcomes for pregnant individuals with mental illness
Leveraging psychobiologic markers of stress to reduce severe maternal morbidity in pregnant people with mental illness
This study is looking at how stress affects pregnant people with mental health challenges, hoping to find ways to reduce serious health issues during pregnancy and improve overall well-being for moms and their babies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10984100 on NIH RePORTER |
What this research studies
This research investigates how psychobiologic markers of stress can be leveraged to reduce severe maternal morbidity in pregnant individuals experiencing mental illness. The approach focuses on understanding the relationship between mental health and complications during pregnancy, aiming to identify specific behavioral and biological pathways that contribute to increased risks. By addressing these factors, the research seeks to develop targeted interventions that can be implemented in clinical settings to improve maternal health outcomes. The study will involve analyzing data and conducting assessments to better understand the impact of mental illness on pregnancy complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant individuals with a diagnosed mental illness.
Not a fit: Patients without mental illness or those not currently pregnant may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and reduced risks for pregnant individuals with mental illness.
How similar studies have performed: Previous research has indicated that addressing mental health issues during pregnancy can lead to significant improvements in maternal health outcomes, suggesting a promising avenue for this approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Panelli, Danielle Mari — Stanford University
- Study coordinator: Panelli, Danielle Mari
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.